Jonathan Lieber

Mr. Jonathan I.
Lieber is an Independent Director at MindWalk Holdings Corp., a Chief Financial Officer & Treasurer at Rallybio Corp., an Independent Director at Decoy Therapeutics, Inc. and a Member-Audit Committee at Atrius Health, Inc. He is on the Board of Directors at MindWalk Holdings Corp.
and Decoy Therapeutics, Inc. Mr. Lieber was previously employed as a Chief Financial Officer by Applied Genetic Technologies Corp., a President & Chief Financial Officer by Organovo Holdings, Inc., an Independent Director by Salarius Pharmaceuticals, Inc., a Chief Financial Officer by Checkmate Pharmaceuticals, Inc., a Chief Financial Officer by Danforth Advisors LLC, a Chief Financial Officer by Histogenics Corp., a Chief Financial Officer & Senior Vice President by Metamark Genetics, Inc., a Chief Financial Officer & Treasurer by Repligen Corp., a Chief Financial Officer & Treasurer by Xcellerex, Inc., a Chief Financial Officer, Treasurer & Senior VP by Altus Pharmaceuticals, Inc., a Vice President by SG Cowen & Co. LLC, and a Member-Health Care & High Yield Group by Salomon Brothers, Inc. He received his undergraduate degree from Boston University and an MBA from The Leonard N Stern School of Business.